When did AtriCure report Q3 2025 earnings?

AtriCure (ATRC) reported Q3 2025 earnings on October 29, 2025 after market close.

What were AtriCure's Q3 2025 revenue and EPS?

AtriCure reported revenue of $134.3M and eps of $-0.01 for Q3 2025.

Did AtriCure beat estimates in Q3 2025?

Revenue missed the consensus estimate of $140.5M by $6.2M. EPS beat the consensus estimate of $-0.11 by $0.10.

How did AtriCure's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 15.8% from $115.9M a year earlier and eps grew 94.1% from $-0.17.

Where can I find AtriCure's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0001323885-25-000103) directly on SEC EDGAR. The filing index links above go to sec.gov.

AtriCure ATRC Q3 2025 earnings

Reported October 29, 2025 · After market close

Revenue$134.3MMiss by $6.2M

EPS-$0.01Beat by $0.10

Revenue estimate$140.5M

EPS estimate-$0.11

Next report

Date not yet announced

Financials

Q3 2025

Income statement

See full

Revenue$134.3M+15.8%

Gross profit$101.3M+16.8%

Operating income$208.0K+103%

Net income-$267.0K+96.6%

EPS (diluted)-$0.01+94.1%

Balance sheet

See full

Cash & equivalents$147.9M+13.4%

Total debt$77.9M-0.4%

Total equity$476.5M+2.5%

Total assets$635.4M+3.3%

Cash flow

See full

Operating cash flow$26.7M+33.6%

CapEx$2.6M-27.8%

Free cash flow$24.1M—

Valuation & ratios

Valuation

as of 09/30/25

See full

Market cap$1.75B+28.3%

Enterprise value$1.68B+28.1%

P/S3.4×+0.3×

Profitability

See full

Gross margin74.9%+0.1pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin6.4%—

Returns & leverage

See full

Return on equity-6.1%-1.3pp

Debt / equity0.2×0.0×

Current ratio3.9×+0.3×

Segments

By product

See full

Appendage management$55.6M+20.9%

Open ablation$46.4M+18.5%

Pain management$22.9M+28.0%

Minimally invasive ablation$9.3M-27.4%

By geography

See full

Total International$25.0M+22.0%

Europe$15.2M+24.2%

Other International$1.7M+28.6%

Versus estimates

Revenue

Q2 2026$153.6MBeat by $1.8M Q1 2026$141.2MBeat by $1.5M Q4 2025$140.5MBeat by $785.4K

Q3 2025$134.3MMiss by $6.2M

Q2 2025$136.1MBeat by $6.0M Q1 2025$123.6MMiss by $7.0M

Diluted EPS

Q2 2026$0.18Beat by $0.18 Q1 2026$0.00Beat by $0.07 Q4 2025$0.06Beat by $0.10

Q3 2025-$0.01Beat by $0.10

Q2 2025-$0.02Beat by $0.13 Q1 2025-$0.14Beat by $0.11

Ask the moment AtriCure reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did AtriCure report Q3 2025 earnings?: AtriCure (ATRC) reported Q3 2025 earnings on October 29, 2025 after market close.
What were AtriCure's Q3 2025 revenue and EPS?: AtriCure reported revenue of $134.3M and eps of $-0.01 for Q3 2025.
Did AtriCure beat estimates in Q3 2025?: Revenue missed the consensus estimate of $140.5M by $6.2M. EPS beat the consensus estimate of $-0.11 by $0.10.
How did AtriCure's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 15.8% from $115.9M a year earlier and eps grew 94.1% from $-0.17.
Where can I find AtriCure's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0001323885-25-000103) directly on SEC EDGAR. The filing index links above go to sec.gov.